Veracyte (VCYT) Shares Outstanding (Diluted Average): 2019-2025
Historic Shares Outstanding (Diluted Average) for Veracyte (VCYT) over the last 6 years, with Sep 2025 value amounting to $79.9 million.
- Veracyte's Shares Outstanding (Diluted Average) rose 1.89% to $79.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.9 million, marking a year-over-year increase of 1.89%. This contributed to the annual value of $78.2 million for FY2024, which is 7.60% up from last year.
- Per Veracyte's latest filing, its Shares Outstanding (Diluted Average) stood at $79.9 million for Q3 2025, which was up 0.05% from $79.9 million recorded in Q2 2025.
- Veracyte's 5-year Shares Outstanding (Diluted Average) high stood at $80.1 million for Q1 2025, and its period low was $63.3 million during Q1 2021.
- In the last 3 years, Veracyte's Shares Outstanding (Diluted Average) had a median value of $77.2 million in 2024 and averaged $76.2 million.
- Data for Veracyte's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 34.06% (in 2021) over the last 5 years.
- Over the past 5 years, Veracyte's Shares Outstanding (Diluted Average) (Quarterly) stood at $67.9 million in 2021, then increased by 5.39% to $71.5 million in 2022, then increased by 1.53% to $72.6 million in 2023, then increased by 7.60% to $78.2 million in 2024, then grew by 1.89% to $79.9 million in 2025.
- Its last three reported values are $79.9 million in Q3 2025, $79.9 million for Q2 2025, and $80.1 million during Q1 2025.